Selected DIDEO Terms — English (DIDEO)

Selected terminology labels for DIDEO. Original publisher/project: Drug-drug Interaction and Drug-drug Interaction Evidence Ontology; credited creators: Anuj Shah; Dan Malone; Jessica Tay-Sontheimer; Jingjing Yu; Jodi Schneider; Philip E. Empey; Richard D. Boyce; William R. Hogan; Mathias Brochhausen. Original source: https://purl.obolibrary.org/obo/dideo.owl; actual download: https://raw.githubusercontent.com/DIDEO/DIDEO/master/dideo.owl; official project record: https://obofoundry.org/ontology/dideo.html. Retrieved 2026-11-07. Version: http://purl.obolibrary.org/obo/dideo/release/2023-10-16/dideo.owl; 2023-10-16. Original artifact SHA-256: 1f4da6b6183d897f972890fac672ef637234da6749ba4db233887439ce59ee1b. Original and public license: CC-BY-4.0; license evidence is embedded in that exact artifact: http://creativecommons.org/licenses/by/4.0/. Source IDs and individual source citations are preserved. Languages: English; explicit tags are retained; untagged English labels are inferred from the OLS language index, with this inference retained in private source notes. No nationality, jurisdiction or cross-language equivalence is inferred. Only active own-project owl:Class primary labels and explicit exact synonyms are included. Deprecated classes, general alternative labels, external namespaces, definitions, relationships and imports are excluded. This is a selected subset, not the complete ontology. Semantic review is ongoing; the resource library does not claim project authorization or endorsement.

概念整理者: Morgan Reed

登录以收藏或派生此词库。

英语
drug-drug interaction management option未评级
chlorzoxazone 6-hydroxylation未评级
reported drug-drug interaction未评级
drug-drug interaction未评级
evidence information from p-glycoprotein transport protein identification experiment using overexpressed cell lines未评级
evidence information from CYP450 recombinant drug metabolism identification experiment using antibody inhibitors未评级
clearance measurement datum未评级
transgenic animal hepatocyte population未评级
drug-drug interaction description from drug package insert未评级
evidence information from chemical analytic characterization of material未评级
clinically relevant potential drug-drug interaction未评级
metabolic potential drug-drug interaction未评级
area under the curve ratio未评级
fold未评级
HBG BC2 cell未评级
evidence information from CYP450 human microsome drug metabolism identification experiment未评级
observational data item about drug-drug interaction未评级
renal clearance ratio未评级
clinical study未评级
human liver S9 fraction未评级
coumarin 7-hydroxylation未评级
evidence information from OATP1B3 inhibition experiment未评级
evidence information from OATP1B1 inhibition experiment未评级
hepatic clearance ratio未评级
evidence information from OATP1B3 transport protein identification experiment未评级
drug maximum concentration measurement datum未评级
evidence information from p-glycoprotein inhibition experiment using overexpressed cell lines未评级
dextromethorphan O-demethylation未评级
evidence data item未评级
midazolam 1'-hydroxylation未评级
pharmacokinetic parameter ratio directionality未评级
E. coli recombinant protein production host cell未评级
evidence information from OATP1B1 transport protein identification experiment未评级
estradiol glucuronosylation未评级
freshly isolated human hepatocyte population未评级
evidence information from observational study未评级
CHO transfected cell未评级
baculovirus-insect recombinant protein production host cell未评级
drug bioavailability assay未评级
precipitant drug role未评级
data item about biological process未评级
evidence information from CYP450 human microsome drug metabolism identification experiment using antibody inhibitors未评级
evidence information from observation-based report未评级
evidence information from drug metabolism identification experiment未评级
material entity participant in drug-drug interaction未评级
evidence information from clinical study未评级
evidence information from observational pharmacokinetic study未评级
evidence information from CYP450 recombinant drug metabolism identification experiment using chemical inhibitors未评级
drug-drug interaction description未评级
Hep G2 transfected cell未评级
information about increase of pharmacokinetic area under the curve未评级
absorbability未评级
percentage value specification未评级
metabolism induction potential drug-drug interaction未评级
293 transfected cell未评级
drug package insert未评级
Hep G2 cell未评级
evidence information from an observation-based case-report of a drug interaction未评级
time to maximum drug concentration ratio未评级
evidence material information未评级
evidence information from drug metabolism induction experiment未评级
evidence information from p-glycoprotein transport protein identification experiment未评级
evidence information content entity未评级
cryopreserved human hepatocyte population未评级
drug package AUC information未评级
metabolism inhibition potential drug-drug interaction未评级
drug-drug interaction description from FDA label information未评级
pharmacokinetic parameter ratio未评级
drug-drug interaction evidence未评级
bufuralol 1'-hydroxylation未评级
evidence information from genotyped pharmacokinetic trial未评级
absorbability measurement datum未评级
evidence information from observation-based adverse drug event report未评级
evidence information from drug transport protein induction experiment未评级
evidence information from pharmacokinetic trial未评级
data item from extrapolation未评级
drug maximum concentration ratio未评级
omeprazole 5-hydroxylation未评级
pharmacokinetic parameter ratio decrease未评级
evidence information from parallel groups drug-drug interaction clinical trial'未评级
diclofenac 4'-hydroxylation未评级
efflux ratio未评级
human intestine S9 fraction未评级
pharmacokinetic area under curve未评级
evidence information from OATP1B3 transport protein identification experiment using overexpressed cell lines未评级
primary total clearance enzyme role未评级
pharmacokinetic interaction signal未评级
narrow therapeutic index未评级
paclitaxel 6-alpha hydroxylation未评级
evidence information from OATP1B3 inhibition experiment using overexpressed cell lines未评级
evidence information from a publicly reported observation-based adverse drug event report未评级
human liver cytosolic fraction未评级
net flux ratio未评级
public adverse event reporting database未评级
bioavailability未评级
half-life ratio未评级
evidence information from p-glycoprotein inhibition experiment未评级
evidence information from non-randomized drug-drug interaction clinical trial未评级
U.S. Food and Drug Administration drug label未评级
number of liver donors未评级

后续 100 个概念